Background Dysregulation of the renin angiotensin system (RAS) has been linked to autonomic dysfunction, fear -related disorders (i.e., PTSD) and increased cardiovascular disease (CVD) risk. We recently demonstrated that following reactivation of a fear memory, the peripheral administration of losartan, an angiotensin type 1 receptor blocker (Agtr1) blocker, disrupted long term cue-dependent fear memory. In order to further analyze the role of brain RAS in fear memory processes, here we examined brain RAS gene expression patterns in the basolateral amygdala (BLA), a brain region essential for fear or threat related memory. We hypothesized that peripheral losartan administration would interfere with the reconsolidation of memory by altering the expression of central RAS and other downstream signaling genes involved in fear memory. Methods Pavlovian auditory fear conditioning, whole-genome RNA-sequencing and RT-qPCR on brain tissue punches were combined to analyze gene expression patterns at early (40mins) and late (4hr) phases of reconsolidation and also after acute losartan treatment (10mg/kg, i.p). Results Following auditory cued fear memory retrieval, mRNA expression of immediate early genes (IEGs) - fos, Egr-1 and Arc in the BLA were rapidly increased at 40mins (2-3-fold, p<0.001; n=8) and returned to baseline at 4hrs. At these same early (40 min) activation and late (4hrs) time-points, RAS gene expression (mRNA) patterns in the BLA and synaptic plasticity genes were also dynamically regulated in a time-dependent manner. Compared to our control (non-retrieval group), at 40 min, we observed 2-3-fold mRNA changes in levels of the angiotensin peptide pre-cursor angiotensinogen - Agt (3-fold p<0.025, n=6) and the angiotensin II converting to angiotensin 1-7 cleaving enzyme - Ace2 (2-fold, p<0.05, n=8) which both returned to control levels at 4 hours. In contrast, at the receptor level, the angiotensin II type 1 receptor (Agtr1) was increased at 4 hours, but not 40 min while the type 2 receptor (Agtr2) was increased at both time points. The mRNA level of brain derived neurotrophic factor (Bdnf), an important synaptic plasticity modulator and downstream to angiotensin II signaling, was also elevated (1-fold, p<0.005, n=8) at 40mins. These gene expression patterns were distinct only for BLA as other brain regions of CA1, PVN and PFC showed no significant change. Finally, we determined whether post-retrieval losartan effects RAS genes in the BLA. We found that losartan prevented the rapid increase in Agt expression (p<0.05, n=8) and further increased Ace2 levels (p<0.01, n=8). Conclusion These results demonstrate that following retrieval of a fear memory, brain Agt expression is dynamically regulated in the basolateral amygdala and its expression is also influenced by losartan administration. These results contribute to further understanding the role of brain RAS in modulating central fear memory processes which may have important translational implications for advancing novel therapeutics for PTSD.
Read full abstract